Calliditas Therapeutics

$30.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.03 (-3.31%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell CALT and other stocks, options, and ETFs commission-free!

About CALT

Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for treatment of patients with the inflammatory renal disease IgA nephropathy. The company was founded by Mikael Bender and Bengt Ã…ke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden. The listed name for CALT is Calliditas Therapeutics AB American Depositary Shares.

CEO
Renée Julie Elisabet Aguiar-Lucander
Employees
16
Headquarters
Stockholm, Stockholm
Founded
2004
Market Cap
731.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.33K
High Today
$30.84
Low Today
$30.53
Open Price
$30.84
Volume
1.56K
52 Week High
$38.00
52 Week Low
$19.00

Collections

CALT Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 18, Pre-Market

You May Also Like

ETX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure